Characterization of pediatric hepatocellular carcinoma reveals genomic heterogeneity and diverse signaling pathway activation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Characterization of pediatric hepatocellular carcinoma reveals genomic heterogeneity and diverse signaling pathway activation

Published:2019-04-11 Issue:7 Volume:66 Page:e27745
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Haines Katherine¹^ORCID,Sarabia Stephen F.²³,Alvarez Karla R.²³,Tomlinson Gail⁴,Vasudevan Sanjeev A.³⁵,Heczey Andras A.³⁶,Roy Angshumoy²³,Finegold Milton J.²,Parsons D. Williams¹³⁶,Plon Sharon E.¹³⁶^ORCID,López‐Terrada Dolores²³

Affiliation:

1. Department of Molecular and Human GeneticsBaylor College of Medicine Houston Texas

2. Department of Pathology and ImmunologyBaylor College of Medicine Houston Texas

3. Texas Children's Cancer CenterTexas Children's Hospital Houston Texas

4. University of Texas Health Sciences Center at San AntonioGreehey Children's Cancer Research Institute San Antonio, Texas

5. Department of SurgeryBaylor College of Medicine Houston Texas

6. Department of PediatricsBaylor College of Medicine Houston Texas

Funder

Cancer Prevention and Research Institute of Texas

National Institute of General Medical Sciences

National Cancer Institute

National Human Genome Research Institute

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.27745

Reference21 articles.

1. Hepatocellular carcinoma in the pediatric population: a population based clinical outcomes study involving 257 patients from the Surveillance, Epidemiology, and End Result (SEER) Database (1973–2011);Lau CSM;HPB Surg,2015

2. Epidemiology of primary hepatic malignancies in U.S. children

3. Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium

4. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma

5. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and immunophenotype correlating with response to immunotherapy in paediatric patients with primary liver carcinoma. A case series;eBioMedicine;2024-06

2. In silico and in vivo anti-angiogenic validation on ethanolic extract of Curcuma longa and curcumin compound in hepatocellular carcinoma through mitogen activated protein kinase expression in male and female wistar rats;Food and Chemical Toxicology;2023-12

3. Preneoplastic liver colonization by 11p15.5 altered mosaic cells in young children with hepatoblastoma;Nature Communications;2023-11-06

4. Molecular Profiling of a Hepatocellular Neoplasm Not Otherwise Specified (HCN-NOS) Demonstrates Distinct Molecular Features in Hepatoblastoma and HCC-Like Components;Pediatric and Developmental Pathology;2023-10-30

5. RSK2 inactivation cooperates with AXIN1 inactivation or β-catenin activation to promote hepatocarcinogenesis;Journal of Hepatology;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3